Hemiparesis clinical trials at UC Health
1 research study open to eligible people
open to eligible people ages 35-75
A study of stereotactic, intracerebral injection of CTX0E03 neural stem cells into patients with moderate to moderately severe disability as a result of an ischemic stroke.
at UC Irvine UCLA UCSD